About Epica International
Epica International is a private company based in Landrum,, South Carolina. It has reported $25,631,030 raised in seven offerings on Form D since December 2014. Its chief executive is Jose Soto III.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2023 | Nov 17, 2023 | $12,664,973of $13.9M target | 200 | $63,325 | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2020 | Apr 23, 2021 | $2,987,510of $3.0M target | 12 | $248K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 5, 2019 | Aug 20, 2019amended Dec 5, 2019 | $3,000,000fully sold | 54 | $55,556 | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 22, 2019 | Apr 5, 2019 | $612,970of $3.0M target | 18 | $34,054 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 21, 2016 | Mar 30, 2016amended Mar 29, 2017 | $726,077of $3.0M target | 3 | $242K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 31, 2015 | Nov 30, 2015amended Mar 29, 2017 | $3,090,500of $5.0M target | 39 | $79,244 | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Jun 5, 2014 | Dec 18, 2014amended Mar 29, 2017 | $2,549,000fully sold | 50 | $50,980 | Equity, Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, seven offerings | $25,631,030 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Epica International's Form D filed Nov 17, 2023.
Earlier filings also listed Gregory Stoutenburgh (director, last listed Apr 2021), Renzo Valleggi (chief technology officer and director, last listed Dec 2019), Frank D'Amelio (chief executive officer and director, last listed Dec 2019), Damiano Fortuna (president and director, last listed Dec 2019), Jerry Sherlock (chief operations officer, last listed Apr 2019), Philip Warth (director, last listed Mar 2017), Michael Fajardo (chief financial officer and director, last listed Mar 2017) and Eric Lindquist (chief medical officer and director, last listed Mar 2017).